Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 1)
Launched by HARVARD UNIVERSITY · Oct 30, 2023
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to help reduce the risk of suicide among U.S. servicemembers and veterans who use the social media site RallyPoint. The study is testing a new approach where peer support is encouraged when someone posts about feeling distressed or having suicidal thoughts. When a post is identified as needing help, the researchers will provide prompts to other users, guiding them on how to respond in a supportive way. This intervention aims to create a more caring community and increase positive interactions among users.
To participate in this trial, you need to be an active user of RallyPoint, as the study focuses on those who regularly engage with the platform. Participants can expect to see messages encouraging them to respond to posts that show signs of distress, helping to foster a supportive environment. The trial is currently recruiting individuals aged 65 and older, and it welcomes participants of all genders. This initiative is important because it aims to provide immediate peer support to those who might be struggling, ultimately working toward reducing the risk of suicide.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals who are active users on the social media site RallyPoint.
- Exclusion Criteria:
- • Individuals who are not active users on the social media site RallyPoint.
About Harvard University
Harvard University, a prestigious Ivy League institution, is a leading sponsor of clinical trials, dedicated to advancing medical research and improving patient outcomes. With a strong emphasis on innovation and interdisciplinary collaboration, Harvard leverages its world-class faculty, cutting-edge facilities, and extensive resources to conduct rigorous clinical studies across various fields, including medicine, public health, and biomedical sciences. The university is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the safety and well-being of participants while contributing valuable insights to the global healthcare community. Through its clinical research initiatives, Harvard aims to translate scientific discoveries into effective treatments and preventive strategies that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported